Bronchial Cancer Clinical Trial
Official title:
Kinetics of Circulating Tumoral Cells in Bronchial Primitive Cancer
| NCT number | NCT03328559 |
| Other study ID # | CTC |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | March 7, 2016 |
| Est. completion date | August 20, 2021 |
| Verified date | August 2021 |
| Source | Groupe Hospitalier Paris Saint Joseph |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The pronostic value of Circulating Tumoral Cells(CTC) 's dosage by the method ISET® (tumoral cell isolation by size) in patients with bronchial cancer was previously demonstrated. However, no kinetic study was ever realized to study the value of the CTC as predictive indicator of answer to the therapy. This project plans to study patients in an early stage and patients at advance stage locally moved forward or metastatic of the disease by evaluation of the presence and the number of CTC before every cure. This collaborative and original study should allow to refine the diagnoses of answer and to plan the possible relapses what would allow a premature institution of the treatment.
| Status | Completed |
| Enrollment | 6 |
| Est. completion date | August 20, 2021 |
| Est. primary completion date | November 30, 2018 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - patients with non-small cell lung cancer - accepting participation Exclusion Criteria: - refusing participation |
| Country | Name | City | State |
|---|---|---|---|
| France | Groupe Hospitalier Paris Saint Joseph | Paris | Ile-de-France |
| Lead Sponsor | Collaborator |
|---|---|
| Groupe Hospitalier Paris Saint Joseph |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | numeration of CTC (circulant tumoral cell) | Day 1 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04802902 -
Feasibility of Immunotherapy Plus Chemotherapy Administration to Patients With Bronchial Cancer in a Hospital-at- Home Setting
|
||
| Completed |
NCT04334239 -
Effectiveness of Care in Certified Cancer Centres in Germany
|
||
| Completed |
NCT03786653 -
Feasibility of Immunotherapy Administration to Patients With Bronchial Cancer in a Hospital-at- Home Setting (ImHADom)
|
||
| Recruiting |
NCT05886075 -
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
|
Early Phase 1 | |
| Completed |
NCT05027490 -
CAncer, NUtrition and Taste 2
|
N/A | |
| Not yet recruiting |
NCT02648087 -
Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer
|
N/A | |
| Completed |
NCT05605236 -
Stereotactic Margins in Localized Bronchial Cancer (T1/T2a, N0)
|
||
| Completed |
NCT03684486 -
Rehabilitation by Effort for Patients With Advanced Bronchial Cancer
|
N/A | |
| Active, not recruiting |
NCT02877043 -
Study of the Quality of Lung Resection
|
N/A |